A. Mansur

R. West, P. Paudyal, Christina J. Jones, 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Side effects from azathioprine in a patient with thiopurine S-methyl transferase deficiency

A. Mansur, J. Berg, L. Ford, 2009 .

Illness perceptions in difficult to treat asthma compared with a depressed psychosis cohort.

A. Mansur, A. Stimpson, J. Fellows, 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Validation of subscales of the Severe Asthma Questionnaire (SAQ) using exploratory factor analysis (EFA)

M. Hyland, S. Fowler, J. Dodd, 2020, Health and Quality of Life Outcomes.

Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma

I. Pavord, R. Chaudhuri, P. Bradding, 2019, American journal of respiratory and critical care medicine.

Composite type-2 biomarker strategy versus a symptom–risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial

I. Pavord, A. Woodcock, P. Howarth, 2020, The Lancet. Respiratory medicine.

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)

I. Pavord, A. Woodcock, Dirk E. Smith, 2015, Thorax.

Preventing unscheduled hospitalisations from asthma: a retrospective cohort study using routine primary and secondary care data in the UK (The PUSH-Asthma Study)—protocol paper

S. Haroon, P. Nagakumar, A. Mansur, 2022, BMJ Open.

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma

I. Pavord, S. Fowler, R. Chaudhuri, 2021, American journal of respiratory and critical care medicine.

Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study

R. Chaudhuri, J. Lordan, P. Bradding, 2019, Thorax.

Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma

J. Hébert, G. Ferguson, A. Mansur, 2018, Journal of asthma and allergy.

Biomarkers of oxidative stress and antioxidants in severe asthma: A Prospective Case-Control Study.

M. Krishna, A. Mansur, S. Manney, 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Suggestive evidence for genetic linkage between IgE phenotypes and chromosome 14q markers.

N. Morton, S. Holgate, A. Markham, 1999, American journal of respiratory and critical care medicine.

Linkage/association study of a locus modulating total serum IgE on chromosome 14q13–24 in families with asthma

S. Holgate, A. Markham, D. Bishop, 2004, Thorax.

A randomised, double-blind, placebo-controlled study to evaluate the efficacy of oral azithromycin as a supplement to standard care for adult patients with acute exacerbations of asthma (the AZALEA trial)

N. Thomson, P. Ind, S. Johnston, 2016 .

Randomised controlled trial of the prostaglandin D2 receptor antagonist fevipiprant in 1 persistent eosinophilic asthma 2

A. Wardlaw, I. Pavord, V. Mistry, 2022 .

S61 Clinical Outcomes and Inflammatory Biomarkers in Current Smokers and Ex-Smokers with Severe Asthma

N. Thomson, C. Brightling, R. Chaudhuri, 2012, Thorax.

Mode of onset and triggers of severe asthma; the severe asthma clinic perspective

A. Mansur, D. Viswam, 2022, Annals of Allergy, Asthma & Immunology.

Development and clinical application of a prednisolone/cortisol assay to determine adherence to maintenance oral prednisolone in severe asthma.

C. Webster, Maged Hassan, A. Mansur, 2020, Chest.

UK consensus statement on the diagnosis of inducible laryngeal obstruction in light of the COVID‐19 pandemic

S. Fowler, J. Hull, J. Haines, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Secretoglobin 1A1 gene and asthma pre‐disposition: what is the evidence?

A. Mansur, A. Mansur, 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Clinical and Experimental Allergy Secretoglobin 1 A 1 gene and asthma predisposition : what is the evidence ?

A. Mansur, 2008 .

Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma

I. Pavord, P. Howarth, F. Symon, 2022, Allergy.

M11 A preliminary biopsychosocial model of Vocal Cord Dysfunction (VCD)

R. Howard, A. Mansur, J. Fellows, 2015 .

Moderate-to-severe asthma in individuals of European ancestry: a genome-wide association study

L. Wain, N. Shrine, C. Billington, 2019, The Lancet. Respiratory medicine.

Symptom based questionnaires predict frequent exacerbations in severe asthma.

A. Mansur, C. Green, J. Marsh, 2021, The journal of allergy and clinical immunology. In practice.

Incorrect Conclusions Concerning Antibiotics and Asthma Exacerbation.

S. Johnston, A. Chauhan, A. Mansur, 2017, JAMA internal medicine.

Lingering Questions Concerning Specific Dietary Fats and Mortality—Reply

S. Johnston, A. Chauhan, A. Mansur, 2017 .

Vocal cord dysfunction and severe asthma: considering the total airway.

J. Ayres, A. Mansur, 2011, American journal of respiratory and critical care medicine.

Relationship between inflammatory status and microbial composition in severe asthma and during exacerbation

I. Pavord, S. Fowler, C. Brightling, 2022, Allergy.

Association study of asthma and atopy traits and chromosome 5q cytokine cluster markers

A. Markham, J. Britton, D. Bishop, 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Late-breaking abstract: Phase 2a randomized placebo-controlled trial of the oral prostaglandin D2 receptor (DP2/ CRTh2) antagonist QAWo39 in eosinophilic asthma

I. Pavord, C. Brightling, A. Wardlaw, 2014 .

The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry

N. Thomson, C. Brightling, R. Chaudhuri, 2014, Thorax.

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.

I. Pavord, N. Thomson, J. Austin, 2013, The Journal of allergy and clinical immunology.

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry

D. Price, C. Brightling, R. Chaudhuri, 2016, Thorax.

Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma.

N. Thomson, C. Brightling, R. Chaudhuri, 2013, The Journal of allergy and clinical immunology.

Vocal cord dysfunction treated with long-term tracheostomy: 2 case studies.

J. Ayres, A. Mansur, D. Mcleod, 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI.

A. Rowe, K. Chung, C. Brightling, 2013, Chest.

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma Asthma Stratification

I. Pavord, S. Walker, R. Djukanović, 2022 .

Prevalence and predictors of adherence to controller therapy in adult patients with severe/difficult-to-treat asthma: a systematic review and meta-analysis

Maged Hassan, A. Mansur, S. Trethewey, 2020, The Journal of asthma : official journal of the Association for the Care of Asthma.

Acid suppression does not reduce symptoms from vocal cord dysfunction, where gastro‐laryngeal reflux is a known trigger

J. Blakey, A. Mansur, K. Woolnough, 2013, Respirology.

Non Random Usage of T Cell Receptor α Gene Expression in Atopy Using Anchored PCR

A. Markham, A. Mansur, D. Holland, 1996 .

Genetic variation at the HLA and TCR loci and the development of allergy and asthma

A. Mansur, 2002 .

Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations

A. Papi, A. Mansur, T. McIver, 2016, Journal of aerosol medicine and pulmonary drug delivery.

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial

I. Pavord, A. Woodcock, P. Howarth, 2018, Trials.

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.

I. Pavord, C. Brightling, A. Wardlaw, 2016, The Lancet. Respiratory medicine.

Management of difficult-to-treat asthma in adolescence and young adults

A. Mansur, Nagakumar Prasad, 2023, Breathe.

Biologic therapy practices in severe asthma; outcomes from the UK Severe Asthma Registry and survey of specialist opinion

I. Pavord, R. Chaudhuri, P. Pfeffer, 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era

P. Pfeffer, S. Message, J. Busby, 2020, Thorax.

Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.

S. Srivastava, A. Mansur, A. Sahal, 2018, Respiratory medicine.

Factors associated with frequent exacerbations in the UK Severe Asthma Registry.

N. Thomson, C. Brightling, R. Chaudhuri, 2021, The journal of allergy and clinical immunology. In practice.

Using prednisolone and cortisol assays to assess adherence in oral corticosteroid dependant asthma: an analysis of test-retest repeatability.

R. Chaudhuri, J. Lordan, P. Bradding, 2020, Pulmonary pharmacology & therapeutics.

Clinical utility of fractional exhaled nitric oxide in severe asthma management

C. Brightling, A. Menzies-Gow, A. Mansur, 2020, European Respiratory Journal.

Global Quality Standard for Identification and Management of Severe Asthma

J. Haughney, P. Chanez, Y. Tohda, 2020, Advances in Therapy.

Case series: the application of “third wave” cognitive behavioural therapies in difficult to treat asthma

R. Kurukulaaratchy, R. Howard, J. Blakey, 2015, The Journal of asthma : official journal of the Association for the Care of Asthma.

Ethnic differences in severe asthma clinical care and outcomes: an analysis of United Kingdom primary and specialist care.

R. Chaudhuri, P. Pfeffer, S. Message, 2021, The journal of allergy and clinical immunology. In practice.

Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma.

N. Thomson, H. Husi, C. Brightling, 2016, Respiratory medicine.

Genome-wide search for asthma genes.

A. Mansur, J. Morrison, 2000 .

Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.

P. Howarth, N. Rahman, R. Luengo-Fernandez, 2019, Health technology assessment.

Dedicated severe asthma services improve health-care use and quality of life.

C. Brightling, R. Chaudhuri, C. Bucknall, 2015, Chest.

Association between exhaled breath condensate nitrate + nitrite levels with ambient coarse particle exposure in subjects with airways disease

R. Harrison, G. Hoek, K. Katsouyanni, 2012, Occupational and Environmental Medicine.

Comparison of the sensitivity of patient-reported outcomes for detecting the benefit of biologics in severe asthma

M. Hyland, S. Fowler, J. Dodd, 2021, Chronic respiratory disease.

Effect of benralizumab in a patient with uncontrolled severe eosinophilic asthma and comorbid chronic rhinosinusitis with nasal polyps refractory to mepolizumab treatment

A. Mansur, 2021, Respiratory medicine case reports.

A Charter to Fundamentally Change the Role of Oral Corticosteroids in the Management of Asthma

G. Canonica, J. Haughney, P. Chanez, 2023, Advances in therapy.

Associations between employment and socio-demographic and health-related factors, in asthmatic patients assessed at a regional severe asthma service.

M. Krishna, A. Mansur, G. Walters, 2022, The journal of allergy and clinical immunology. In practice.

Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma

I. Pavord, A. Woodcock, P. Howarth, 2021, European Respiratory Journal.

Continuous terbutaline infusion in severe asthma in adults: a retrospective study of long-term efficacy and safety

J. Ayres, Duncan R. Wilson, A. Mansur, 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.

The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?

S. Fowler, R. Chaudhuri, P. Pfeffer, 2020, ERJ Open Research.

The association between asthma and obstructive sleep apnea (OSA): A systematic review

A. Turner, S. Wharton, A. Mansur, 2019, The Journal of asthma : official journal of the Association for the Care of Asthma.

Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review.

A. Turner, S. Wharton, A. Mansur, 2018, Respiratory medicine.

Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study

F. Percival, N. Barnes, A. Menzies-Gow, 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

Dedicated severe asthma services improve healthcare utilisation and quality of life

N. Thomson, K. Chung, C. Brightling, 2013 .

Effect of monitoring adherence to regular inhaled corticosteroid (ICS) alone or in combination with a long-acting β2-agonist (LABA) using electronic methods on asthma outcomes: a narrative systematic review

J. Marriott, A. Mansur, Mohammed Almutairi, 2023, BMJ open.

Phenotypic and functional translation of IL33 genetics in asthma.

L. Wain, N. Shrine, C. Billington, 2020, The Journal of allergy and clinical immunology.

Genome-wide association study to identify genetic determinants of severe asthma

L. Wain, N. Shrine, I. Sayers, 2011, Thorax.

Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma

I. Pavord, R. Chaudhuri, P. Bradding, 2019, American journal of respiratory and critical care medicine.

Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma.

I. Pavord, N. Thomson, J. Austin, 2013, The Journal of allergy and clinical immunology.

Long-term safety and efficacy of fluticasone/formoterol combination therapy in asthma.

A. Mansur, K. Kaiser, 2013, Journal of aerosol medicine and pulmonary drug delivery.

Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical Trial.

N. Thomson, P. Ind, S. Johnston, 2016, JAMA internal medicine.